Want to see IN:MKPL full AI Analyst Report?

M K Proteins Limited (MKPL) Price & Analysis

0 Followers

MKPL Stock Chart & Stats

₹6.89

-₹0.11(-1.36%)

At close: Jan 08 4:00 PM EST

₹6.89

-₹0.11(-1.36%)

Day’s Range― - ―

52-Week Range₹3.80 - ₹8.84

Previous CloseN/A

Volume181.52K

Average Volume (3M)20.59K

Market Cap

₹1.56B

Enterprise Value₹2.22B

Total Cash (Recent Filing)₹4.38M

Total Debt (Recent Filing)₹371.38M

Price to Earnings (P/E)23.5

Beta0.97

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.18

Shares Outstanding375,372,000

10 Day Avg. Volume17,806

30 Day Avg. Volume20,591

Financial Highlights & Ratios

PEG Ratio-1.18

Price to Book (P/B)1.92

Price to Sales (P/S)0.38

P/FCF Ratio76.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improved LeverageLeverage has trended meaningfully lower, improving financial flexibility and reducing refinancing pressure. A lower debt-to-equity ratio and rising equity provide a stronger capital cushion that supports investment or working-capital needs and lowers solvency risk over the medium term.

Revenue ReboundA strong FY2026 revenue recovery indicates renewed demand or better commercial execution versus prior years. Sustained top-line growth improves scale economics and creates opportunity to restore margins if cost control and pricing discipline are maintained over the coming quarters.

Stable Asset BaseGrowing equity and broadly stable assets signal a steadier balance-sheet foundation. This stability reduces the likelihood of forced asset sales, supports credit metrics if profitability normalizes, and gives management room to invest in operations or product initiatives.

Bears Say

Margin CompressionSharp and sustained margin erosion materially weakens profitability and the firm's ability to self-fund growth. Low gross and net margins limit buffering against input-cost shocks, constrain reinvestment capacity, and raise risk that modest sales swings will push the company into losses.

Weak Cash ConversionInconsistent and often negative operating cash flow shows poor cash conversion versus reported profits, raising liquidity and execution risk. Limited free cash flow reduces capacity for capex, debt paydown or dividends and increases sensitivity to working-capital volatility.

Volatile Top-line And EarningsRecurrent revenue and earnings volatility complicates planning and indicates structural demand or execution issues. This inconsistency makes margin recovery harder to sustain, raises forecasting risk for stakeholders, and may reflect competitive or pricing pressures.

M K Proteins Limited News

M K Proteins Closes Trading Window Ahead of Q1 FY2026 Results

M K Proteins Limited ( ($IN:MKPL) ) has issued an announcement. M K Proteins Limited has announced the...

1M ago

MKPL

MKPL FAQ

What was M K Proteins Limited’s price range in the past 12 months?

M K Proteins Limited lowest stock price was ₹3.80 and its highest was ₹8.84 in the past 12 months.

What is M K Proteins Limited’s market cap?

M K Proteins Limited’s market cap is ₹1.56B.

When is M K Proteins Limited’s upcoming earnings report date?

M K Proteins Limited’s upcoming earnings report date is Aug 18, 2026 which is in 15 days.

How were M K Proteins Limited’s earnings last quarter?

M K Proteins Limited released its earnings results on May 29, 2026. The company reported ₹0.03 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.03.

Is M K Proteins Limited overvalued?

According to Wall Street analysts M K Proteins Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does M K Proteins Limited pay dividends?

M K Proteins Limited does not currently pay dividends.

What is M K Proteins Limited’s EPS estimate?

M K Proteins Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does M K Proteins Limited have?

M K Proteins Limited has 375,372,000 shares outstanding.

What happened to M K Proteins Limited’s price movement after its last earnings report?

M K Proteins Limited reported an EPS of ₹0.03 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of M K Proteins Limited?

Currently, no hedge funds are holding shares in IN:MKPL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M K Proteins Limited

M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, cottonseed, soybean, palm, canola, and bleached rice bran oils. Furthermore, it provides by-products like rice bran fatty acid oils, rice bran waxes, gums, and spent earth. The firm also participates in the import and trade of both edible and non-edible oils. Founded in 2012, the company's operations are headquartered in Ambala, India.